We are live on ! Find out more
CRBU icon

Caribou Biosciences
CRBU

126 hedge funds and large institutions have $338M invested in Caribou Biosciences in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 19 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 19

82% more capital invested

Capital invested by funds: $185M → $338M (+$153M)

69% more call options, than puts

Call options by funds: $616K | Put options by funds: $364K

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

8.87% more ownership

Funds ownership: 71.3% → 80.17% (+8.9%)

4% more funds holding

Funds holding: 121 → 126 (+5)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
126
Holders Change
+5
Holders Change %
+4.13%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
28
Increased
58
Reduced
19
Closed
21
Calls
$616K
Puts
$364K
Net Calls
+$252K
Net Calls Change
+$247K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$26.6M
2
DM
Deerfield Management
New York
+$21.7M
3
APM
Avidity Partners Management
Texas
+$20.4M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.9M
5
PBA
Paradigm Biocapital Advisors
New York
+$18.3M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.64M
2
Bank of America
Bank of America
North Carolina
-$2.76M
3
MSKCC
Memorial Sloan Kettering Cancer Center
New York
-$2.31M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.85M
5
Jane Street
Jane Street
New York
-$771K
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
26
Rafferty Asset Management
New York
$2.43M +$3.15M +507,400 New
7IH
27
72 Investment Holdings
Connecticut
$2.27M – – –
Walleye Capital
28
Walleye Capital
New York
$2.24M -$161K -25,985 -5%
WP
29
Woodline Partners
California
$2.21M +$2.86M +461,538 New
Goldman Sachs
30
Goldman Sachs
New York
$1.89M +$775K +124,968 +46%
JFG
31
Jefferies Financial Group
New York
$1.43M +$1.86M +300,000 New
Mirae Asset Global Investments
32
Mirae Asset Global Investments
South Korea
$1.4M +$250K +40,222 +16%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.26M +$374K +60,242 +30%
Barclays
34
Barclays
United Kingdom
$1.22M +$1.46M +236,020 +1,296%
Adage Capital Partners
35
Adage Capital Partners
Massachusetts
$1.21M – – –
N
36
Nuveen
North Carolina
$1.19M +$100K +16,162 +7%
Citigroup
37
Citigroup
New York
$1.06M +$1.21M +194,816 +739%
TI
38
Trexquant Investment
Connecticut
$1.02M +$777K +125,277 +141%
BC
39
Bruce & Co
Illinois
$956K – – –
Wellington Management Group
40
Wellington Management Group
Massachusetts
$952K +$1.24M +199,105 New
Two Sigma Investments
41
Two Sigma Investments
New York
$940K +$912K +146,989 +296%
LCM
42
Laurion Capital Management
New York
$790K +$1.02M +165,192 New
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$766K +$205K +33,017 +26%
WHG
44
Westwood Holdings Group
Texas
$729K +$946K +152,436 New
UBS Group
45
UBS Group
Switzerland
$724K +$221K +35,628 +31%
GIM
46
Granahan Investment Management
Massachusetts
$652K +$62.5K +10,081 +8%
Millennium Management
47
Millennium Management
New York
$646K -$3.64M -587,389 -81%
RJA
48
Raymond James & Associates
Florida
$633K -$485K -78,164 -37%
Alyeska Investment Group
49
Alyeska Investment Group
Illinois
$598K +$776K +125,000 New
AI
50
Atom Investors
Texas
$590K +$766K +123,427 New
1
2
3 4 5

CRBU Hedge Fund Activity: Q3 2023 in Review

126 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q3 2023, worth a combined $338M — up 82% from $185M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CRBU positions and 21 closed out — a net gain of 7 holders — while 58 added to existing stakes and 19 trimmed.

The largest buyer was State Street, adding an estimated $26.6M. The largest seller was Millennium Management, cutting an estimated $3.64M.

  • 126 institutional investors held Caribou Biosciences (CRBU) as of Q3 2023, up from 121 in Q2 2023.
  • Funds reported $338M of Caribou Biosciences stock for Q3 2023, up 82% quarter-over-quarter.
  • 28 funds opened new Caribou Biosciences positions in Q3 2023 and 21 closed out, a net change of +7 holders.
  • The largest Caribou Biosciences buyer in Q3 2023 was State Street, an estimated $26.6M added.
  • The largest Caribou Biosciences seller in Q3 2023 was Millennium Management, an estimated $3.64M sold.

Based on aggregated 13F filings for Q3 2023.